scispace - formally typeset
S

S.E. Moses

Researcher at Health Protection Agency

Publications -  17
Citations -  1007

S.E. Moses is an academic researcher from Health Protection Agency. The author has contributed to research in topics: HBsAg & Hepatitis B virus. The author has an hindex of 8, co-authored 16 publications receiving 311 citations. Previous affiliations of S.E. Moses include Newcastle upon Tyne Hospitals NHS Foundation Trust.

Papers
More filters
Journal ArticleDOI

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.

Katherine A Twohig, +607 more
TL;DR: In this paper, the authors compared the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes and found that outbreaks of the Delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variants.
Journal ArticleDOI

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

Clark D Russell, +355 more
TL;DR: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study as discussed by the authors is an ongoing, prospective cohort study recruiting inpatients from 260 hospitals in England, Scotland, and Wales, conducted by the ISARIC Coronavirus Clinical Characterization Consortium.
Journal ArticleDOI

Hepatitis B in pregnancy

TL;DR: One in six women had active HBV requiring treatment or high HBV-DNA levels that would benefit from antiviral treatment to reduce the transmission risk.
Journal ArticleDOI

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.

Paul Elliott, +592 more
- 02 Nov 2021 - 
TL;DR: In this article, the authors assessed RT-PCR swab-positivity in the REAL-time Assessment of Community Transmissibility (RACT) in many countries associated with the Delta variant.
Journal ArticleDOI

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.

Thomas M Drake, +346 more
TL;DR: In this paper, a prospective, multicentre cohort study included patients of any age admitted to hospital with a confirmed or highly suspected SARS-CoV-2 infection leading to COVID-19 between Jan 17 and Aug 10, 2020, and secondary outcomes were disease severity at presentation, admission to critical care, receipt of invasive ventilation, non-invasive ventilation, use of supplementary oxygen, and acute kidney injury.